UNSPSC 51192019: Allopurinol sodium

This classification denotes a xanthine oxidase inhibitor and uricosuric agen with the molecular formula C5H3N4O.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 428673RC2Z, chemically known as 1,5-dihydro-4h-pyrazolo(3,4-d)pyrimidine-4-one but more generally known as allopurinol sodium, which bears US NIH Compound Identifier 2094. The base compound, Allopurinol, comes in other forms, including di-methyl, ribonucleoside, riboside, riboside, and 5-monophosphate.

UNSPSC 51192019 Allopurinol sodium, a Commodity code, does not align with recent state and local procurement activity. The three most recent opportunities tagged under this pharmaceutical code involve a District Attorney's office dog procurement (Washington County, Oregon), athletic training services for fire and police departments (City of Tucson), and medical aid supplies including first aid kits and antiseptic products (City of Tampa Fire Rescue). None of these solicitations concern allopurinol sodium or any pharmaceutical product matching the code's scope. The mismatch suggests either miscoding in the state and local database or a systematic cataloging error; the code shows no recent activity actually buying the product it nominally describes.

The geographic spread represented in the three tagged opportunities spans Oregon, Arizona, and Florida, with issuing bodies including a county purchasing office, a city government, and a municipal fire department. Without relevant recent opportunities under this code, there is no actionable signal regarding genuine market demand, issuing-body patterns, or geographic concentration for allopurinol sodium procurement in state and local government.